Literature DB >> 18226883

Influence of hydroxypropyl-beta-cyclodextrin on transdermal penetration and photostability of avobenzone.

Jing Yang1, Cody J Wiley, Donald A Godwin, Linda A Felton.   

Abstract

The objective of the present study was to determine the effects of hydroxypropyl-beta-cyclodextrin (HPCD) complexation on the transdermal penetration and photostability of a model ultraviolet A (UVA) absorber, butyl methoxydibenzoylmethane (avobenzone), and to determine the influence of complexation on in vivo photoprotection. Avobenzone-HPCD complexation was demonstrated by differential scanning calorimetry. Formulations containing 0.12 mg/ml avobenzone and up to 30% (w/w) HPCD were prepared. Transdermal penetration was conducted using a modified Franz diffusion cell apparatus. As the concentration of HPCD was increased from 0% to 20%, transdermal permeation increased. Maximum flux occurred at 20% HPCD, where sufficient cyclodextrin was present to completely solubilize all avobenzone. When the concentration of HPCD was increased to 30%, transdermal penetration decreased, suggesting the formation of an avobenzone reservoir on the skin surface. Photostability of avobenzone was investigated under 100, 250, and 500 kJ/m2 UVA irradiation. The 30% HPCD formulation was the most photostable, followed by 20%, 10%, and 0% formulations. In vivo, the 30% HPCD formulation afforded the best photoprotection, as evidenced by the lowest extent of sunburn cell formation and edema induction. This work indicates that inclusion of HPCD in sunscreen formulations may enhance photoprotection by reducing both skin penetration and photodecomposition of UV absorbers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18226883     DOI: 10.1016/j.ejpb.2007.12.015

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Sunscreens and their usefulness: have we made any progress in the last two decades?

Authors:  Nick Serpone
Journal:  Photochem Photobiol Sci       Date:  2021-02-18       Impact factor: 3.982

2.  Transdermal delivery of cyclodextrin-solubilized curcumin.

Authors:  Raksha Ghanghoria; Prashant Kesharwani; Hrushikesh Bharat Agashe; N K Jain
Journal:  Drug Deliv Transl Res       Date:  2013-06       Impact factor: 4.617

3.  Effects of solvent and micellar encapsulation on the photostability of avobenzone.

Authors:  Kerry M Hanson; Miles Cutuli; Tiffany Rivas; Miranda Antuna; Jessica Saoub; Nathan T Tierce; Christopher J Bardeen
Journal:  Photochem Photobiol Sci       Date:  2020-02-26       Impact factor: 3.982

4.  Experimental and computational studies of physicochemical properties influence NSAID-cyclodextrin complexation.

Authors:  Linda A Felton; Carmen Popescu; Cody Wiley; Emilio Xavier Esposito; Philippe Lefevre; Anton J Hopfinger
Journal:  AAPS PharmSciTech       Date:  2014-04-10       Impact factor: 3.246

5.  Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation.

Authors:  Fang Wang; Wenbo Yu; Carmen Popescu; Ahmed Ashour Ibrahim; Dongyue Yu; Ryan Pearson; Alexander D MacKerell; Stephen W Hoag
Journal:  Pharm Dev Technol       Date:  2022-04-25       Impact factor: 3.915

6.  Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia.

Authors:  Srinivasa M Sammeta; Siva Ram K Vaka; S Narasimha Murthy
Journal:  J Control Release       Date:  2009-11-14       Impact factor: 9.776

7.  A novel murine model for the in vivo study of transdermal drug penetration.

Authors:  Gábor Eros; Petra Hartmann; Szilvia Berkó; Eszter Csizmazia; Erzsébet Csányi; Anita Sztojkov-Ivanov; István Németh; Piroska Szabó-Révész; István Zupkó; Lajos Kemény
Journal:  ScientificWorldJournal       Date:  2012-01-04

8.  Synthesis of hierarchically mesoporous silica with encapsulated avobenzone as a UV protection filter.

Authors:  Wei-Hsun Wang; Hsin-Tung Liang; Yuan-Ting Yang-Wang; Chi-Jen Shih
Journal:  RSC Adv       Date:  2020-04-21       Impact factor: 3.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.